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2013; revised manuscript received December 5,deep palmar arches, which limits the potential for limb-
threatening ischemia (3). Yet cannulation of the RA
carries a risk for vessel occlusion, ranging from 0.8% to
30.0% (4). It is therefore recommended that the integrity of
the palmar arches of the hand be conﬁrmed before trans-
radial access (TRA) is established for arterial pressure
monitoring (5) or to perform coronary catheterization (6,7)
or vessel harvesting for coronary artery bypass grafting (8).See page 1842The modiﬁed Allen test (AT), despite its known limita-
tions (9,10), has been used to evaluate the patency of the
ulnopalmar arches, with an arbitrary threshold of 6 to 10
seconds to achieve full blushing of the hand after the release
of RA compression (11). This has resulted in the exclusion
of as many as 27% of patients who have been referred
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1834for TRA (12). Whether the AT
can predict ischemic complica-
tions after TRA is controversial,
and several centers, including
ours, no longer perform the AT
before TRA (13–17). However,
30-min RA occlusion, achieved
in an experimental setting withthe use of an external clamping device, led to increased thumb
capillary lactate, suggestive of hand ischemia, in patients with
abnormal AT results compared with those with normal
AT results (18). This ﬁnding cautioned the interventional
community about the possible risks of not properly selecting
patients for TRA.
We sought to investigate in a clinical (i.e., not experi-
mental) setting the safety and feasibility of transradial
catheterization across the full spectrum of AT results by
serially assessing thumb capillary lactate as well as other
markers of hand ischemia and ulnar ﬂow.Methods
Study design and population. The RADAR (Should
Intervention Through Radial Approach be Denied to Pa-
tients With Negative Allen’s Test Results) study is a single-
center prospective study designed to evaluate the safety and
feasibility of transradial catheterization and intervention in
patients with abnormal or intermediate AT results compared
with those with normal AT results.
Patients undergoing elective or urgent coronary angiog-
raphy were stratiﬁed on the basis of the results of the AT
into 3 groups: normal, intermediate, and abnormal. Patients
were enrolled consecutively until the pre-speciﬁed number
of at least 60 patients was reached in each AT result group.
Exclusion criteria were hemodynamic instability, including
ongoing chest pain or recent ST-segment elevation myocar-
dial infarction; planned intra-aortic balloon pump insertion;
previous trauma or surgical intervention in the instrumented
arm; and absence of a valid radial pulse in at least one arm.
The institutional ethics committee approved this protocol,
and all participants gave written informed consent.
Modiﬁed AT. The modiﬁed AT was performed as follows.
After vigorous compression of both the radial and ulnar
arteries, the patient was asked to forcefully clench one hand
several times to expel blood from the hand. The hand was
then opened, avoiding wrist and ﬁnger hyperextension,
before release of ulnar artery compression. The amount of
time to achieve maximal palmar blush was measured after
compression release of the ulnar artery with continuing
occlusive pressure of the RA. AT results were deﬁned as
normal, intermediate, or abnormal if maximal palmar blush
after compression released was achieved within 5 s, between
6 and 10 s, or after 10 s, respectively.
Plethysmography and pulse oximetry. Plethysmography
was recorded with a pulse oximeter with the clamp sensor
applied to the thumb before and immediately after RAcompression, as previously described (Barbeau test) (11), and
results were divided into 4 types: pattern A, no damping of
pulse tracing immediately after RA compression; pattern B,
damping of pulse tracing; pattern C, loss of pulse tracing
followed by recovery of pulse tracing within 2 min; and
pattern D, loss of pulse tracing without recovery within 2
min. A single investigator (C.P.) who was blinded to AT
results and thumb capillary lactate measurements performed
all plethysmographic assessments. A reverse Barbeau test
(i.e., after ulnar artery compression) was systematically
implemented after the procedure to screen for the patency of
the previously instrumented RA. In cases of pattern D
readings, RA occlusion was conﬁrmed on duplex echocar-
diographic examination.
Thumb capillary lactate assessment. A single drop of
blood from the distal thumb was collected to assess thumb
capillary lactate concentration (Accutrend Lactate analyzer;
Boehringer Mannheim, Mannheim, Germany), as previ-
ously described (18), before catheterization, immediately
before radial sheath removal at the end of the procedure,
immediately before removal of the RA compressing system
(TR Band, Terumo Corporation, Tokyo, Japan), the day
after the procedure, at 30 days, and at 1 year.
Ulnar frame count. To objectively evaluate an index of
ulnar ﬂow, the number of cine frames required for contrast
to ﬁrst reach the standardized distal ulnar landmark (the
ulnar frame count) was measured at radial sheath insertion
(baseline measurement before cardiac catheterization) and
removal (ﬁnal measurement after cardiac catheterization)
with a frame counter (Dicom Viewer 2.0, Rubo Medical
Imaging BV, Aerdenhout, the Netherlands) after setting
image acquisition at 30 frames/s.
The ﬁrst frame used for ulnar frame counting is the ﬁrst
frame in which dye fully enters the arterial sheath after auto-
mated 6-ml contrast injection through the side port using the
Avanta Fluid Management Injection System (Medrad, Inc.,
Pittsburgh, Pennsylvania) (Fig. 1). In analogy to the previ-
ously developed Thrombolysis In Myocardial Infarction
frame count (19), this occurs when 3 criteria are met: 1) a
column of nearly full or fully concentrated dye must extend
across the entire width of the origin of the arterial sheath; 2)
dye must touch both borders of the head of the sheath; and 3)
there must be anterograde motion to the dye.
The last frame is deﬁned as the frame when dye ﬁrst
reaches the distal ulnar landmark, deﬁned as the tract of the
ulnar artery, which lies on the virtual orthogonal axis con-
necting it to the entry site of the side port into the radial
arterial sheath (Fig. 1). To standardize the recognition of
the ulnar landmark, the side port of the radial sheath was
strained before ﬁlming internally to the wrist to orthogonally
cross the ulnar artery (Fig. 1). Full opaciﬁcation of the ulnar
artery was not required. Online Videos 1 and 2 showing how
the ulnar frame count was generated, are provided in the
online version of this article.
Handgrip strength test. Patients were asked to hold the
dynamometer in the hand, which was selected for
Figure 1 Ulnar Frame Count
An example of how the ulnar frame count is quantiﬁed before (A to C) and after (D to F) catheterization. (A,D) First still frame obtained immediately after radial sheath insertion
before (A) or immediately after (D) catheterization. The side port of the radial sheath is strained internally to the wrist before ﬁlming to orthogonally cross the passage of the
ulnar artery. (B,E) The ﬁrst frame used for ulnar frame counting is the one in which the dye fully enters the arterial sheath via the side port, corresponding to frame #36 before
(B) or frame #37 after (E) catheterization. (C,F) The last counted frame is deﬁned as the frame when dye ﬁrst reaches the distal ulnar landmark, deﬁned as the tract of the ulnar
artery, which lies on the virtual orthogonal axis connecting it to the entry site of the side port, corresponding to frame #97 before (C) or to frame #64 after (F) catheterization.
The ulnar frame count was thus quantiﬁed as 61 before and 27 after catheterization. See accompanying Online Videos 1 and 2.
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1835catheterization and AT screening, with the arm at right
angles and the elbow by the side of the body. Patients were
asked to squeeze the dynamometer with maximal isometric
effort, and the best result from 3 trials with at least 15 s of
recovery between each effort was recorded at each time
point. Results are expressed in kilograms, and mean range
values are 48 to 52 kg for men and 26 to 30 kg for women.
Discomfort rating. Each patient quantiﬁed the pain or
discomfort as well as the amount of dysesthesia or soreness of
the instrumented arm and/or hand serially after intervention.
A visual analogue scale with 100-mm bars was used to stan-
dardize symptom collection for both pain or discomfort and
dysesthesia. Amark at 0mm indicated no discomfort, whereas
a mark at 100 mm indicated the most severe discomfort. The
results of the 2 questionnaires were then summed and divided
by 10, resulting in a uniform scale ranging from 0 to 20.
Follow-up. Patients returned for study visits at 30 days and
1 year, at which the AT, thumb capillary lactate, plethys-
mography, and handgrip strength test were performed.
Statistical analysis. The primary objective of this study was
to show that the thumb capillary lactate concentration after
the procedure, assessed immediately before radial sheathremoval, was inﬂuenced by the AT result, as previously re-
ported (18). Using a conservative assumption of previous
ﬁndings (18), we expected post-procedural thumb capillary
lactate concentration to be in the range of 1.5, 1.65, and 1.8
mmol/l in patients with normal, intermediate, and abnormal
AT results, respectively. This corresponds to an increase of
respectively 10% or 20% thumb capillary lactate concen-
tration in patients with intermediate or abnormal results
compared with normal AT results. Sixty patients per group
were required to reach a study power >95%, with a sigma
of 0.4 mmol/l and a type I error of 5%, which was con-
ﬁrmed in a Monte Carlo simulation using the simpower
Stata library (StataCorp LP, College Station, Texas).
Categorical variables are expressed as frequencies, whereas
continuous variables are expressed as median (interquartile
range [IQR]) or mean  SD when the normality assump-
tions were met. Baseline or procedural continuous variables
were compared between groups using the Wilcoxon rank
sum test, whereas for binary variables, the chi-square or
Fisher exact test was used as appropriate.
One-way analysis of variance was used to compare the
primary endpoint across groups, stratiﬁed by AT result, after
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1836normal distribution of the variable was demonstrated using
the Kolmogorov-Smirnov goodness-of-ﬁt test. The general
linear mixed model for repeated measures was used to assess
the changes in the primary and secondary study endpoints
over time and their possible interaction with AT results by
setting the time of the assessment as the within-subjects
covariate and AT result group as the between-subjects
factor. Post-hoc comparisons were performed using the
Tukey honestly signiﬁcantly different test. To assess the
change in plethysmographic readings over time in each AT
stratum, the Friedman test was applied. Two-sided
p values <0.05 were considered signiﬁcant. All analyses
were performed using Stata version 11.1 or SPSS version 20
(IBM Statistics, Armonk, New York).
Results
From October 2007 to June 2009, a total of 942 patients
were screened, and 203 were ﬁnally recruited into the study,
of whom 83, 60, and 60 had normal, intermediate, and
abnormal AT results, respectively (Fig. 2).
Patients with abnormal AT had a higher prevalence of
insulin-dependent diabetes and less frequently underwent
previous homolateral transradial catheterization compared
with patients with normal or intermediate test results
(Table 1). The pattern of plethysmographic readings differed
across the 3 AT result groups (p < 0.0001) (Fig. 3). Pattern
A decreased from 83% in the normal to 2% in the abnormal
AT result groups, whereas pattern D was not observed in the
normal or intermediate groups but was recorded in as many
as 40% of patients in the abnormal AT result category.
No ischemic vascular or bleeding access-site complica-
tions occurred during or after the transradial procedures, and
no patient underwent vascular surgery.
Kinetics of capillary thumb lactate. Capillary thumb
lactate is shown in Figure 4. The primary endpoint (post-
procedural lactate) did not differ among the 3 study groups
immediately after catheterization (1.85  0.93 mmol/l in the
normal group, 1.85 0.66 mmol/l in the intermediate group,
and 1.97  0.71 mmol/l in the abnormal group; p ¼ 0.59 on
1-way analysis of variance). Similarly, capillary thumb lactate
did not differ across the 3 study groups at baseline or at other
time points.Mean capillary thumb lactate increased by almost
20%, irrespective of AT results, immediately before trans-
radial occlusion removal (2.21  0.93 mmol/l in the normal
group, 2.16  1.21 mmol/l in the intermediate group, and
2.10  0.98 mmol/l in the abnormal group; p < 0.002 vs.
baseline on post-hoc analysis). Similar results were obtained in
a sensitivity analysis when patients were stratiﬁed on the basis
of baseline plethysmographic readings.
Discomfort rating and handgrip strength test. Self-
reported discomfort rating consistently peaked at the time
of radial occlusion, whereas AT results failed to identify
patients with a greater likelihood of developing symptoms
during or after transradial catheterization (Fig. 4). Similarly,
maximal isometric strength on the handgrip strength testwas not affected by AT results, and it did not change over
time.
Ulnar frame count. The ulnar frame count was signiﬁcantly
affected by both AT results (median 34 [IQR: 19 to 64], 55
[IQR: 43 to 88], and 70 [IQR: 51 to 125] in the normal,
intermediate, and abnormal AT result groups, respectively,
p < 0.001), as well as the timing of assessment with respect
to the transradial procedure (median 56 [IQR: 32 to 85]
before vs. 28 [IQR: 14 to 60] after catheterization,
p < 0.001), with no interaction between the timing of
assessment (i.e., before or after catheterization) and the AT
result (p ¼ 0.30) (Fig. 4). Patients with normal AT results
had signiﬁcantly lower ulnar frame counts both before and
after transradial catheterization compared with those with
abnormal test results (p < 0.01 on post-hoc analysis). Yet
after catheterization, the ulnar frame count decreased rela-
tively more in patients with intermediate (median 31 [IQR:
27 to 35]) or abnormal (median 28 [IQR: 20 to 32]) AT
results compared with those with normal AT results (median
11 [IQR: 8 to 15]).
RA patency and plethysmographic readings at follow-up.
At day 1 after catheterization, the absence of the previously
instrumented radial pulse was observed in 5 completely
asymptomatic patients, 1 of which occurred in a patient in the
abnormal AT result group. The presence of collateral ﬂow
through a patent ulnar circulation was conﬁrmed on Doppler
echocardiographic examination in all 5 patients. At 30 days, 1
patient in the intermediate AT result group, who had pattern
C on plethysmography before TRA, showed spontaneous RA
recanalization. Pattern A on plethysmography was recorded
in this individual at both 30-day and 1-year follow-up.
Spontaneous RA recanalization also occurred at 30 days
in a patient in the normal AT result group. The RA re-
mained occluded in the other 3 patients, who remained
asymptomatic with no discomfort and unchanged thumb
capillary lactate and handgrip strength at follow-up. The
plethysmography readings remained consistent over time
in patients with normal Allen’s test at baseline (p ¼ 0.56).
In contrast, plethysmographic readings showed an increase
of patterns A and B over time at the expenses of pattern C
in the intermediate AT result group and patterns C and D
in the abnormal AT result group (p < 0.001 for both).
Discussion
This is the ﬁrst study investigating the safety and feasibility
of TRA across the full spectrum of AT results in a clinical
(i.e., not experimental) setting. The results of our investi-
gation can be summarized as follows.
First, post-procedural thumb capillary lactate was not
affected by AT results, and it did not increase after TRA
compared with pre-procedural levels.
Second, self-reported hand discomfort or perceived hand
disability as well as maximal isometric strength of the hand
and forearm muscles did not differ among the 3 AT result
groups after the procedure and at follow-up.
Figure 2 Study Proﬁle
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1837Third, thumb capillary lactate levels were consistently
increased across the whole spectrum of AT results before
RA bandage removal. Hand ischemic symptoms and patient
reports also peaked at this time point in all patients, with no
detectable inﬂuence of pre-procedural AT results.
Fourth, the ulnar frame count was signiﬁcantly affected by
pre-procedural AT result. Patients with normal compared
with thosewith abnormal pre-proceduralAT results displayed
signiﬁcantly lower ulnar frame counts, suggestive of greater
ulnar blood ﬂow, immediately after arterial sheath insertion.
Although the difference in ulnar frame counts persisted after
catheterization across the 3 AT groups, there was a distinct
and signiﬁcant post-procedural improvement (i.e., a count
reduction) only in patients with baseline abnormal AT results.
Finally, the patency of the ulnopalmar arches of the hand
varied over time in patients who underwent TRA, with
those showing less prominent ulnar and ulnopalmar collat-
eralization (i.e., patients with intermediate or abnormal
AT results) displaying improvements after TRA. This was
conﬁrmed by both the changes in the plethysmographic
readings observed in patients with intermediate and
abnormal AT results at follow-up (pattern D, which was
observed in 40% of patients in the AT-negative group,
dropped to 10% at 24 h and to a single-digit ﬁndingthereafter) and the identiﬁcation of distinct ulnar ﬂow on
Doppler examination and the absence of ischemic symptoms
despite RA occlusion in the 2 patients with non-normal AT
results and plethysmographic pattern C or D before TRA.
Thus, altogether these ﬁndings suggest that the patency
of the ulnopalmar arches of the hand is highly dynamic,
and vascular reserve inherent in the hand circulation can
be recruited during and after TRA, especially in patients
with poor collateral circulation at baseline, thus preventing
detectable objective and subjective signs of hand ischemia
during and after transradial catheterization.
Our observations do not lend support to the concept that
normal AT results are a prerequisite for selecting patients
who can safely undergo TRA. This may explain the paradox
that has been repeatedly observed in recent years (13,16) that
although TRA is becoming increasingly more popular
worldwide (1), and several thousands of patients have
undergone transradial procedure either with false-positive
AT results or with no assessment of palmar arch circu-
lation, only very few cases of hand ischemia after TRA
have been recently reported (20–22). Importantly, none of
them demonstrated a clear association with the presence
of inadequate ulnar and ulnopalmar vessel patency before
the procedure (20–22).
Table 1 Baseline Characteristics of the Patients Stratiﬁed by AT Time
Allen’s Test Time (s)
p Value
0–5
(n ¼ 83)
6–10
(n ¼ 60)
>10
(n ¼ 60)
Age, yrs 70 (64–76) 71 (60–76) 71.5 (64–77) 0.56
Men 58 (70%) 49 (82%) 42 (70%) 0.22
Weight, kg 76 (67–83) 76 (69–87) 77 (68–89) 0.67
Body mass index, kg/m2 26 (24–28) 26 (24–30) 27 (25–31) 0.12
Diabetes 20 (24%) 14 (23%) 18 (30%) 0.66
Insulin-dependent diabetes 3 (4%) 1 (2%) 7 (12%) 0.03
Hypertension 64 (78%) 41 (68%) 48 (80%) 0.27
Hyperlipidemia 38 (46%) 28 (47%) 29 (48%) 0.97
Current cigarette use 22 (27%) 14 (23%) 11 (18%) 0.48
Creatinine clearance, ml/min 80.7 (64–103) 81.1 (62–102) 79.2 (66–100) 0.49
Prior percutaneous coronary intervention 14 (17%) 10 (16.6%) 10 (16.6%) 0.99
Prior coronary artery bypass grafting 2 (2.4%) 10 (6.0%) 2 (3.3%) 0.12
Prior instrumentation of homolateral RA
for coronary angiography/intervention
7 (8.4%) 10 (16.7%) 2 (3.3%) 0.04
Systolic pressure, mm Hg 140  12 139  14
At sheath insertion 139 (129–141) 139 (132–144) 136 (122–149) 0.44
At sheath removal 142 (131–147) 140 (130–147) 139 (120–163) 0.26
Heart rate, beats/min
At sheath insertion 64 (52–73) 63 (50–71) 64 (53–74) 0.84
At sheath removal 142 (131–147) 140 (130–147) 139 (120–163) 0.26
Left ventricular ejection fraction, % 51  12 49  13 49  12 0.87
142 (131–147) 140 (130–147) 139 (120–163) 0.26
Indication for coronary catheterization
Stable angina 27 (32.5%) 22 (36.7%) 15 (25%) 0.33
Unstable angina 23 (27.7%) 22 (36.7%) 18 (30%) 0.48
Non–ST-segment elevation myocardial infarction 24 (28.9%) 13 (21.7%) 17 (28.3%) 0.49
Dilated cardiomyopathy or valvular heart disease 9 (10.8%) 3 (5%) 10 (16.7%) 0.10
Patients who underwent isolate coronary angiography 33 (39.7%) 25 (41.7%) 29 (48.3%) 0.58
Patients who underwent coronary angiography
followed by ad hoc intervention
50 (60.3%) 35 (58.3%) 31 (51.7%)
Duration of the transradial procedure, min 51  26 47  27 49  26 0.54
Medical therapy
Aspirin 53 (88%) 69 (84%) 54 (90%) 0.56
Clopidogrel 48 (80%) 58 (71%) 44 (73%) 0.45
Beta-blockers 48 (81%) 66 (81%) 47 (78%) 0.88
Statins 48 (81%) 60 (74%) 46 (77%) 0.60
ACE inhibitors 51 (86%) 73 (90%) 52 (87%) 0.74
Calcium-channel blockers 8 (14%) 13 (16%) 8 (13%) 0.88
Nitrates 21 (36%) 22 (27%) 11 (18%) 0.11
Warfarin 4 (7%) 2 (2%) 3 (5%) 0.47
Values are median (interquartile range), n (%), or mean  SD.
ACE ¼ angiotensin-converting enzyme; AT ¼ Allen test; RA ¼ radial artery.
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1838The feasibility and preliminary safety of transulnar cath-
eterization and intervention have also been reported in un-
selected patients or even those with previously documented
homolateral RA occlusion, with no evidence of hand
ischemia during or after the procedure (23,24).
The presence of compensatory recruitable collateral vessels
in the hand is well established (18,25–27), and contrary to
previous beliefs that the palmar arches may be incomplete in
a sizable proportion of patients, autopsy studies have recently
shown that either the deep or superﬁcial palmar arch is
always complete in cadaver dissections (28).Consistent with our ﬁndings, Greenwood et al. (18)
observed a progressive increase of blood ﬂow in the prin-
cipal artery of the thumb after external RA occlusion, espe-
cially in patients with abnormal AT results. Moreover, the
majority of these patients with apparently no patency of the
ulnopalmar arches of the hand developed good functioning
of the palmar arches during a relatively short (i.e., 30 min)
period of external RA compression. This observation sup-
ports the concept that anatomically pre-existing collateral
vessels can be functionally recruited during a relatively brief
episode of hand ischemia (18).
Figure 3 Plethysmographic Readings at Baseline and Follow-Up
(A) Plethysmographic readings at baseline stratiﬁed on the basis of Allen test AT result. (B) The pattern of plethysmographic readings in patients with normal AT results
remained consistent at follow-up (p ¼ 0.56). (C) Plethysmographic readings showed an increase of the prevalence of patterns A and B over time at the expenses of pattern C
in patients with intermediate AT results (p < 0.001). (D) Plethysmographic readings showed an increase of the prevalence of patterns A and B over time at the expenses
of patterns C and D in patients with abnormal AT results (p < 0.001).
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1839At variance with our ﬁndings, Greenwood et al. (18)
observed signiﬁcant increases in thumb capillary lactate in
patients with abnormal AT results, which has been inter-
preted as a demonstration that TRA should not be pursued
in this patient population. Our study, which was designed to
reproduce in a much larger sample and in a clinical (i.e., not
experimental) context the previous ﬁndings on capillary
lactate elevation, failed to do so. It is conceivable to speculate
that the difference in the study designs (i.e., experimental
with external RA compression vs. real-world consecutive
patients undergoing TRA) might account for such a
discrepancy in study results. External compression of the RA
not only occludes the artery but also invariably increases
tissue pressure within the wrist compartments, which may
preclude or hamper functional recruitment of pre-formed
collateral vessels. Interestingly, in our study, thumb capil-
lary lactate did not peak after TRA, but it did so immedi-
ately before RA bandage release, irrespective of AT results.
Vascular hemostasis was obtained in our study with the use
of the TR Band system, which has been designed to selec-
tively compress from outside the RA. Although we cannot
exclude the possibility that the use of the TR Band in our
clinical practice may at least partially affect ulnar ﬂow in a
more prominent way compared with the previously used
external compressor device (18), it remains intriguing tospeculate that also in our study, the external compression of
the RA determined the increase in thumb capillary lactate.
Whether the implementation of the patent hemostasis
technique prevents the increase of thumb capillary lactate
requires further investigation (29).
Study limitations. We have developed the ulnar frame
count to obtain an angiographic proxy of intraprocedural
collateral circulation of the hand. Our study shows a clear
association between this new angiographic index and AT
results. Yet hand collateralization largely depends on the
superﬁcial and deep palmar arches, which were not directly
assessed or quantiﬁed in the present analysis. The present
observation that TRA is both feasible and apparently safe
in patients with abnormal AT results, who constituted
roughly 10% of the screened population in our study, should
be regarded as preliminary. Only 60 patients with abnormal
AT results were evaluated with respect to the clinical safety
of TRA in our study. Thus, the risk for hand ischemia
if TRA is performed routinely in these patients may
range from 0% to 6%, on the basis of the 95% conﬁdence
intervals. The MATRIX (Minimizing Adverse Haemm-
horragic Events by TRansradial Access Site and Systemic
Implementation of angioX; NCT01433627) study is
currently investigating whether AT results and plethysmo-
graphic readings before transradial intervention predict the
Figure 4
Thumb Capillary Lactate, Ulnar Frame Counts, Handgrip Stress Test, and Self-Reported Discomfort Rates Over Time
Across AT Results
(A) The levels of thumb capillary lactate did not differ after compared with before catheterization (cath) irrespective of Allen test (AT) results obtained at baseline. Thumb
capillary lactate peaked immediately before arterial bandage removal in all AT result groups. *p< 0.002 versus baseline values in post-hoc analysis. (B) Patients with normal AT
results showed lower ulnar frame counts both before and after catheterization compared with patients with abnormal AT results. Ulnar frame count was signiﬁcantly lower after
compared with the value before catheterization in patients with abnormal AT results. *p < 0.05 versus patients with abnormal AT results in post-hoc analysis for the difference
of ulnar frame counts after minus before catheterization. (C) Handgrip test at baseline and follow-up. (D) Self-reported hand discomfort rating after transradial catheterization.
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1840occurrence of local ischemic complications in a large
and unselected patient population with acute coronary
syndromes.Conclusions
Our study provides proof of concept for a paradigm shift in
cardiovascular intervention, as the widespread, but un-
proved, belief that normal AT results are a prerequisite for
selecting patients before TRA could not be conﬁrmed. No
clinical or subclinical sign of hand ischemia was detected
in patients with abnormal AT results undergoing TRA. A
conﬁrmatory study focusing on clinical endpoints and
involving a larger patient population is ongoing.Reprint requests and correspondence: Dr. Marco Valgimigli,
Thoraxcenter, Ba 587, Erasmus Medical Center, Rotterdam, the
Netherlands. E-mail: m.valgimigli@erasmusmc.nl.REFERENCES
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APPENDIX
For accompanying videos and their legends, please see the online version of
this article.
